Cargando…
The Past, Present, and Future of a Human T-Cell Leukemia Virus Type 1 Vaccine
Human T-cell leukemia virus type 1 (HTLV-1) is an oncogenic human retrovirus which causes a lifelong infection. An estimated 5–10 million persons are infected with HTLV-1 worldwide – a number which is likely higher due to lack of reliable epidemiological data. Most infected individuals remain asympt...
Autores principales: | Tu, Joshua J., Maksimova, Victoria, Ratner, Lee, Panfil, Amanda R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114509/ https://www.ncbi.nlm.nih.gov/pubmed/35602078 http://dx.doi.org/10.3389/fmicb.2022.897346 |
Ejemplares similares
-
Human T-Cell Leukemia Virus Type 1 Envelope Protein: Post-Entry Roles in Viral Pathogenesis
por: Maksimova, Victoria, et al.
Publicado: (2022) -
Vaccination against Lyme disease: past, present, and future
por: Embers, Monica E., et al.
Publicado: (2013) -
Anaerobic Fungi: Past, Present, and Future
por: Hess, Matthias, et al.
Publicado: (2020) -
40 years of the human T-cell leukemia virus: past, present, and future
por: Tagaya, Yutaka, et al.
Publicado: (2019) -
Editorial: Phage Therapy: Past, Present and Future
por: Abedon, Stephen T., et al.
Publicado: (2017)